Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability
AUTOR(ES)
Chin, Alex C.
FONTE
National Academy of Sciences
RESUMO
Proteinase-activated receptor 1 (PAR1)-mediated inflammation remains poorly understood. Here we characterize previously unrecognized effects of PAR1-induced apoptosis signaling, which contributes to epithelial barrier dysfunction. Incubation of epithelial cells with PAR1 agonists induced apoptosis and increased epithelial permeability in a caspase-3-dependent manner. Similarly, studies in vivo demonstrated that intracolonic infusion with PAR1 agonists increased colonic permeability in mice, and that this effect was abolished by pretreatment with a caspase-3 inhibitor. PAR1 agonists induced tight junctional zonula-occludens 1 disruption and apoptotic nuclear condensation. Investigation into signaling pathways showed that these effects were dependent on caspase-3, tyrosine kinase, and myosin light chain kinase. Conversely, the Src kinase inhibitor PP1 augmented zonula-occludens 1 injury and nuclear condensation induced by PAR1 agonists. These results support a role for proteinases and PARs in intestinal disease and provide new directions for possible therapeutic applications of PAR1 antagonists.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=196934Documentos Relacionados
- Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2
- A role for proteinase-activated receptor–1 in inflammatory bowel diseases
- Epithelial effects of proteinase-activated receptors in the gastrointestinal tract
- Essential role for proteinase-activated receptor-2 in arthritis
- Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2
